ARQT

ARCUTIS BIOTHERAPEUTICS INC

Healthcare | Mid Cap

-$0.01

EPS Forecast

$104.5

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.01

Revenue Forecast:

$104.5

EPS Surprise Forecast:

$0.027

Revenue Surprise Forecast:

$5

Post-release price volatility - Very high

Post-release Overnight Move:

±10.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

66%

Probability of beating revenue consensus:

74%

Probability of beating both EPS & revs consensus:

54%

Probability of missing both EPS & revs consensus:

14%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

1.21

Earnings volatility

EPS standard deviation:

$0.18

Revenue standard deviation:

$19

As % of share price:

0.77% HIGH

As % of market cap:

0.68% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.22

Revenue 95th %ile:

$129

EPS 75th %ile:

$0.06

Revenue 75th %ile:

$111

EPS 25th %ile:

-$0.06

Revenue 25th %ile:

$99

EPS 5th %ile:

-$0.20

Revenue 5th %ile:

$84

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

43% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

48% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$22

Bid-ask per Share:

$0.05